More info..

Mitsubishi Shipbuilding Co., Ltd., a part of Mitsubishi Heavy Industries (MHI) Group, today completed the handover of WAKASHIO MARU, a training ship for National Institute of Technology, Toyama College (NIT, Toyama College).
More info..

三菱重工グループの三菱造船株式会社（社長：上田 伸、本社：東京都港区、以下、三菱造船）は13日、独立行政法人国立高等専門学校機構 富山高等専門学校向け練習船「若潮丸」を引き渡しました。
More info..

Mitsubishi Heavy Industries, Ltd. (MHI) today announced its strategic intent to work toward the introduction of a 10-megawatt (MW) class centrifugal chiller for next-generation AI data centers in the North American market, targeting industrial-grade AI computing infrastructure.
More info..

Hari Raya Aidilfitri in the month of Syawal is a cherished time of celebration and time-honoured family traditions, with the kitchen often becoming the heart of the festivities.
More info..

Hitachi, Ltd. announced today that it has received an order from Chubu Electric Power Grid for Hitachi Energy's EconiQ(R) 550 kilovolt (kV) sulfur hexafluoride (SF6)-free gas-insulated switchgear (GIS).
More info..

Honda Motor Co., Ltd. (Honda) today announced that it has made a decision to cancel the development and market launch of three EV (electric vehicle) models that had been planned for production in North America.
More info..

Japantastics, Inc. is proud to launch of a new collection featuring Kodaimoji artworks by Kei Sato, a Japanese calligrapher and contemporary artist who reimagines ancient Chinese scripts - such as oracle bone and bronze inscriptions - as modern expressions of art. These early forms of writing, dating back more than 3,000 years, are recognized as the origins of modern Chinese characters and as vessels of timeless human emotion and spirituality.
More info..

Hondaは、事業環境の変化などを踏まえた四輪電動化戦略の見直しの一環として、北米で生産を予定していたEV（電気自動車）3車種の開発・発売の中止などを決定しました。また、これら戦略の見直しに伴い、2026年3月期連結業績で損失が発生する見通しとなったことから、このたび同期の通期連結業績予想を修正しました。
More info..

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that it is launching an initiative to raise public awareness of the importance of sleep in collaboration with the smartphone application "Pokemon Sleep"
More info..

NEC Corporation (NEC; TSE: 6701) has developed a first-of-its-kind physical AI (*1) that proactively controls robots to help reduce human stress. This technology utilizes a proprietary "world model" (*2) from NEC to predict human movement and psychological states, quantitatively estimating a person's level of stress.
More info..

佐藤木工代表佐藤惠一郎氏は、宝珠悉皆師（ほうじゅしっかいし：宝石プロデューサー）の那須勲氏と共に3月19日から25日の7日間、東京銀座のギャラリーの「ギャルリーラー」において、二人展 唯装論〜聖なる虚飾〜を開催します。
More info..

エーザイ株式会社（本社：東京都、代表執行役 CEO：内藤晴夫）は、このたび、スマートフォン向けアプリ『Pokémon Sleep』とのコラボレーションを通じて、眠りの大切さを広く伝える啓発活動に取り組むことをお知らせします。
More info..

Hondaは、2026年3月19日（木）から3月22日（日）まで、神奈川県横浜市のパシフィコ横浜にて開催される「ジャパンインターナショナルボートショー2026※」に出展し、新色「スポーティーホワイト」を施した大型船外機「BF350」を国内で初めて展示します。
More info..

NEC's data assimilation technology (patent pending) was used to correct data errors, and observed data was compared with simulated data in order to calculate carbon accumulation rates with a high degree of accuracy, achieving a daily margin of error of 9.4%.
More info..

CEOジム・ケラー率いるAIコンピューティング企業Tenstorrentは本日、TT-QuietBox 2（Blackhole）を発表した。
More info..

Tenstorrent, the AI computing company led by CEO Jim Keller, today announced TT-QuietBox 2 (Blackhole).
More info..

Everest Medicines (1952.HK) announced the commercial launch of VELSIPITY(R) (etrasimod arginine tablets) in Mainland China, highlighted by the issuance of the first prescription at The First Affiliated Hospital of Sun Yat-sen University, marking a milestone in patient access in the region. According to reports, on the day the first prescription was issued in mainland China, VELSIPITY(R) was simultaneously prescribed in eight tertiary hospitals across seven key cities'Guangzhou, Shanghai, Hangzhou, Xi'an, Chongqing, Beijing, and Nanjing'achieving immediate coverage of patients in major regions nationwide on its launch day.
More info..

エーザイ株式会社（本社：東京都、代表執行役 CEO：内藤晴夫、以下エーザイ）は、2026 年 3 月17 日から 21 日にかけてデンマーク コペンハーゲンおよびバーチャルで開催される第 20 回アルツハイマー病・パーキンソン病学会（International Conference on Alzheimer's and Parkinson's Diseasesand related neurological disorders：AD/PD™ 2026）において、抗アミロイド β（Aβ）プロトフィブリル抗体レカネマブ（一般名、製品名「レケンビ®」）を含む、当社のアルツハイマー病（AD）領域の研究成果として、3 件の口頭発表を含む６件の発表を行うとともに、1 件のシンポジウムを主催することをお知らせします。
More info..